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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S250Conclusions: Knees that were replaced (KRs) had lower baseline carti-
lage thickness and greater longitudinal (1 year) cartilage loss than non-
KRs, the differences being strongest in both tibiae. Cartilage loss in the
weight-bearing femur (a region commonly showing the greatest rate and
sensitivity to change), in contrast showed less discrimination. The ability
to discriminate between KRs and non-KRs was greater for “earlier” KRs
(within 2 years after measurement of cartilage loss) than for those who
received KR “later” (year 2-4 after measuring cartilage loss).
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PREDICTORS OF FATIGUE IN PATIENTS WITH HIP AND KNEE
OSTEOARTHRITIS
K.D. Allen y,z, H.B. Bosworth y,z, C.J. Coffman y,z, A.S. Jeffreys y, E.Z.
Oddone y,z, W.S. Yancy, Jr. y,z. yDurham VA Med. Ctr., Durham, NC, USA;
zDuke Univ. Med. Ctr., Durham, NC, USA
Purpose: Fatigue is emerging as an important outcome for patients
with osteoarthritis (OA), but little is known about factors that predict
fatigue severity. This study examined associations of demographic and
clinical factors with fatigue in a cohort of patients with hip and / or knee
OA.
Methods: Participants were n¼291 patients enrolled in a clinical trial of
a combined patient and provider intervention for managing OA at the
Durham Veterans Affairs Medical Center (mean age ¼ 61, SD¼9, 90%
male, 53% non-white - primarily African American). All measures were
from baseline assessments. Fatigue was assessed with a 10cm visual
analog scale (range 0-10) that asked participants to report how much
fatigue has been a problem for them during the past week; anchors
were “Fatigue is no problem” and “Fatigue is a major problem.”
Potential predictors included participant age, race (white vs. non-
white), gender, education (some vs. no college), self-rated health
(excellent, very good, or good vs. fair or poor), pain severity (Western
Ontario and McMasters University Osteoarthritis Index pain subscale),
insomnia (Insomnia Severity Index), and depressive symptoms (Patient
Health Questionnaire-8). Simple linear regression models examined
associations of each individual predictor variable with fatigue, then
a multivariable model was ﬁt including all predictors that were signif-
icantly associated (p<0.01) with fatigue in simple regression models.
Results: The mean fatigue score was 4.8 (SD¼3.1). In simple regression
models, older age was associated with slightly lower fatigue (b¼ - 0.07,
95%CI ¼ -0.1, -0.04; p<0.001), and the following were associate with
more fatigue: fair / poor self-rated health (b¼2.2, 95%CI ¼ 1.3, 3.1;
p<0.001), greater insomnia severity (b ¼ 0.21, 95%CI ¼ 0.2, 0.3,
p<0.001), greater pain severity (b¼ 0.4, 95%CI¼ 0.3, 0.5; p<0.001), and
greater depressive symptoms (b ¼ 0.35, 95%CI ¼ 0.3, 0.4; p<0.001). In
the multivariable model, variables that remained associated with
fatigue were insomnia severity (b ¼ 0.06, 95%CI ¼ 0.01, 0.1; p¼0.0),
pain severity (b ¼ 0.20, 95%CI ¼ 0.1, 0.3; p<0.001), depressive symp-
toms (b ¼ 0.21, 95%CI ¼ 0.1, 0.3; p<0.001).
Conclusions: Fatigue severity was relatively high in this cohort of
patients with OA; mean values on the fatigue visual analog scale were
comparable to those seen in patients with rheumatoid arthritis.
Demographic factors including age, as well as general health, were not
associated with fatigue in the multivariable model. However, key clin-
ical variables related to OA - pain, depressive symptoms, and insomnia -
were associated with more fatigue. These results highlight that fatigue
is part of a cluster of OA-related symptoms that generally worsen with
greater disease severity. Because of its impact on daily activities and
quality of life, fatigue is an important issue to address among patients
with OA.475
MEN WITH EARLY DEGREES OF KNEE OA HAVE ALTERATIONS IN
VOLUNTARY ACTIVITY OF THE VASTUS LATERALIS MUSCLE AND
DECREASES IN ECCENTRIC KNEE EXTENSOR TORQUE
S.M. Mattiello, P.R. Serrão, K. Gramani-Say, F.A. Vasilceac, G.C. Lessi, A.B.
Oliveira. UFSCar, São Carlos - SP, Brazil
Purpose:Weakness of the muscles around the knee joint is common in
individuals with knee OA, especially quadriceps muscle weakness.
Moreover, in these patients the failure of the muscular voluntary
activity has been considered an important contributing factor in
reducing the strength of knee extension. Therefore, investigating these
aspects is essential to directing rehabilitation programs. The aim of thisstudy was to evaluate the knee extensor torque (KET) and electro-
myographic (EMG) activity of subjects with early stages of knee oste-
oarthritis (OA) and to compare with healthy subjects.
Methods: Forty men participated in this study: control group (CG;
n¼18; healthy subjects; 51.86.4 years) and osteoarthritis group (OAG;
n¼22; subjects with grade I or II knee osteoarthritis; 528.1 years). The
assessment of knee extensor torque was performed using an isokinetic
dynamometer (Biodex Multi-Joint System 3, Biodex Medical Inc., NY,
USA). Concentric and eccentric KET were evaluated at angular speeds of
90/s and 180/s simultaneously with electromyographic activity eval-
uation of the Vastus Lateralis (VL) muscle(Root Mean Square value -
RMS). The data were analyzed using Statistica software (version 7,
StatSoft, Inc., Tulsa, USA). For the intergroup analysis, we used the
independent t-test and the Mann-Whitney U test (a<0.05).
Results: Signiﬁcant differences were found between the groups in
eccentric KET at 90/s (p¼0.01) and at 180/s (p¼0.04), and in RMS
during the eccentric contractions, also at both angular velocities
(p<0.01), with higher values for the CG.
Conclusion: Thus, men with grade I or II knee OA have decreased
strength of the eccentric KET and decreased in muscular voluntary
activity, indicating neuromuscular adaptations. The eccentric training of
the knee extensor muscles should be emphasized, beginning in the
early stages of the disease.
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THE EFFECT OF AGE ON THE WOMAC TOTAL WITH CONTINUOUS
VERSUS INTERMITTENT CELECOXIB TREATMENT IN PATIENTS WITH
OSTEOARTHRITIS
M. Noyes Essex, P. Bhadra Brown, G.H. Sands. Pﬁzer Inc, New York, NY,
USA
Purpose: Continuous nonsteroidal anti-inﬂammatory drug (NSAID)
treatment has been shown to be signiﬁcantly more efﬁcacious than
intermittent dosing, over a 22-week period, in preventing subsequent
ﬂares in patients with osteoarthritis (OA) of the knee or hip who
successfully treated an initial ﬂare. We set out to characterize the effect
of age on efﬁcacy, as measured by Western Ontario and McMaster
Universities Osteoarthritis Index (WOMAC) Total score, of continuous
daily celecoxib treatment vs intermittent celecoxib treatment.
Methods: Exploratory analysis of a clinical trial was conducted to
determine if WOMAC Total score during a blinded post-randomization
period differed among patients aged less than 60 or 60 years or more.
858 patients aged 18 to 80 with OA of the knee or hip, meeting Amer-
ican College of Rheumatology criteria, were randomized to receive
celecoxib 200 mg qd either as “continuous” (daily) or “intermittent”
(only when needed to treat OA ﬂare meeting predeﬁned criteria)
treatment. Analyses were performed on the intention-to-treat (ITT)
population ( 1 dose of study medication post-randomization) and
ﬂare-modiﬁed ITT population (all ITT patients with OA ﬂares  14 + 2
days duration), using a 2-sided type I error rate of 0.05.
Results:Mean ages were 51.3 (n ¼ 236) and 67.2 (n ¼ 195) years in the
continuous groups and 51.2 (n ¼ 220) and 66.7 (n ¼ 207) years in the
intermittent groups. For patients aged < 60 years, WOMAC Total least
squares mean (LSM) change from randomization to ﬁnal visit was 1.10
(SD 0.95) in the continuous group and 5.32 (SD 0.98) in the intermittent
group (P < 0.002). LSM change from randomization to ﬁnal visit in
patients aged 60 years was 2.24 (SD 1.06) in the continuous group and
4.60 (SD 1.03) in the intermittent group (P < 0.111). Primary results
showed that while WOMAC Total scores were comparable at random-
ization, LSM increases (worsening) in WOMAC Total during double-
blind treatment were signiﬁcantly less in patients receiving continuous
treatment than those receiving intermittent treatment.
In the ﬂare-modiﬁed ITT population, WOMAC Total LSM change from
randomization to ﬁnal visit in patients aged < 60 years receiving
continuous treatment was -0.05 (SD 1.08) vs 3.66 (SD 1.21) in the
intermittent group (P< 0.023). LSM change from randomization to ﬁnal
visit in the  60 years ﬂare-modiﬁed ITT population was -0.22 (SD 1.26)
vs 2.72 (SD 1.23) in the continuous and intermittent groups, respec-
tively (P ¼ 0.097). WOMAC Total LSM increases were less in the
continuous group than the intermittent group, irrespective of patients’
age, though only signiﬁcantly in those aged < 60 years for both the ITT
and ﬂare-modiﬁed ITT populations. Negative LSM change indicates
improvement in WOMAC Total.
Conclusions: Daily celecoxib treatment was signiﬁcantly more efﬁca-
cious, as assessed by the WOMAC Total score, than intermittent use for
